Twitter Linkedin-in

Immuno UK: In-Person

May 2022 | London, UK
Part of the
Immuno Series
Immuno US:
In-Person
Tumor Microenvironment:
Online
Immuno UK:
In-Person
Preclinical Immuno-Oncology: Online
Book Now
Immuno UK
May 2022 | London, UK

Designing & delivering innovative immunotherapies to transform cancer care

Download Agenda
Register

Gain actional insights into the approaches impacting the immunotherapy field through 50+ outstanding presentations  tackling key discussion points in immuno-oncology, immunology and inflammation.

Programme

Benefits to Attending...

  • Gain a forward-looking perspective on the opportunities and challenges impacting market growth in immuno-oncology. Our congress brings together immuno-oncology experts across six streams to provide a comprehensive look at the key trends in this industry, from therapeutic strategies and modelling through to the latest clinical data
  • Hear case studies across a variety of key therapeutic strategies currently being applied in discovery and clinical research: combination therapies, T-cell strategies, checkpoint inhibitors, oncolytic viruses, bispecific drugs and cancer vaccines
  • Advance your understanding of topical technological innovation, from single cell analysis approaches to biomarker technologies like liquid biopsies, immunohistochemistry and Cytof
  • Examine the latest challenges and technological innovations in preclinical development with discussions on animal modelling techniques and screening strategies along with key, preclinical considerations to drive successful entry into the clinical phase
  • Unparalleled networking opportunities. Take advantage of ample in-person and online networking opportunities to enable high-level scientific and business discussions
  • Gain the latest insights into the tumour microenvironment. See how spatial biology, imaging and pathology are elucidating the key biology of solid tumours, and highlighting potential therapeutic approaches
  • Supported digitally on our fully featured online event platform, with selected presentations available to watch on-demand and extensive networking features

Last Year’s Agenda at a Glance

Pre-Event Symposium

  • Takara Bio Symposium - Emerging strategies to improve cell & gene immunotherapies

Day One

  • Discovery & Development: Cell & Gene Therapies, Cancer Vaccines and Oncolytic Viruses
  • Biomarkers in Immuno-Oncology
  • Mechanisms & Novel Treatments in Autoimmunity

Day Two

  • Discovery & Development: Antibodies, Macrophages and Checkpoint Inhibitors
  • Translational & Preclinical Development
  • Targeting the Tumour Microenvironment

Digital Day

  • Presentations & interactive sessions on all above topics

Pre-Event Webinars

You don't have to wait until May to get involved - register for our complimentary live webinars here.
Presented by our expert speakers, these webinars will give you advance insight into topics that will be covered at the event.

Pre-Event Webinars

You don't have to wait until August to get involved - register for our complimentary live webinars here.
Presented by our expert speakers, these webinars will give you advance insight into topics that will be covered at the event.

Key Speakers

The 2022 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

Below were some of the speakers of 2020’s Immuno Series UK: Virtual

Céline Adessi

Celine Adessi

F. Hoffmann-La Roche Ltd.

Jonathan Pachter

Jonathan Pachter

Verastem

Mario Ehlers

Mario Ehlers

Boehringer Ingelheim

Lindy Durrant

Lindy Durrant

Scancell
Omid Vafa, TeneoBio

Omid Vafa

TeneoBio
Graham Pockley, NTU

Graham Pockley

Nottingham Trent University

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.

Networking Drinks & Dinner

Relax after a busy first day at the event with access to the vibrant drink’s reception followed by dinner
Enquire

Panel Discussion

A deep dive into the best strategies to translate a proof of concept into the clinic
Enquire

Roundtable Discussions

Discussions on key industry growth areas within immuno-oncology and autoimmunity
Enquire

Supported Digitally

Can't attend in-person? Our fully featured online platform runs alongside the event with a dedicated Digital Day to round off the conference after the two days on-site

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.
Download Brochure
There was a good mix of science and company presentations with focus on new technologies.
Vice President Process DevelopmentAchilles Therapeutics
The event featured super interesting talks, cutting edge topics and very relevant clinical data. Great overview of new technologies. I found the round tables very interesting and useful. The even provided complete update on the field of Immuno-Oncology.
ScientistImmunocore
I enjoyed learning about new technologies to address Fc crosslinking problem for costimulatory receptors on T cells and about novel approaches to immunotherapy, such as neutrophils attacking tumour cells.
Senior ScientistCancer Research UK
We have received very good support from Oxford Global when organising our one to one client meetings.
Sales Manager EMEAPersonalis
The congress was well organised and very good for networking opportunities with prospective clients.
Product ManagerCharles River
Content Hub Graphic Carousel
Oxford Global Content HUB
Access complementary resources including Webinars, Q&A Sessions, Newsletters and much more.
Immuno Key Image Carousel
Biomarkers & Immuno Series US
The sister-event to Immuno Series UK, taking place this October in San Diego, USA.
Carousel
Upcoming Live Webinar
Upcoming Webinar from Personalis' Robert Power on Enabling the Expansive Interrogation of a Tumour and its Micro-environment from a Single Sample for all Precision Oncology Biomarker Discovery Applications
Q&A
Q&A
Bonnie Hammer, Vice President of Biologics Development, Invenra, Inc discusses "The Impact of Biparatopic Antibodies on Immuno-Oncology"
Immuno UK PEN Carousel
Pre-Event Newsletter
Insight from the expert speakers and sponsors of the 2019 Event.
Immuno UK PER Carousel
Post-Event Report
Statistics, feedback, photos and more from the 4th Annual Advances in Immuno-Oncology Congress.

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.